Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Curran

Showing results (901-910 of 965) with videos related to

Pageof 97
Sort By:
Blood Advances|June 24, 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registrySamuel John, Kevin J Curran, Erin M Hall, et al.
Pediatrics|October 13, 2020
Transitional Care Interventions for Youth With Disabilities: A Systematic ReviewBen B Levy, Jessica Z Song, Dorothy Luong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trialMark R Gilbert, Meihua Wang, Kenneth D Aldape, et al.
ACS Medicinal Chemistry Letters|October 16, 2024
Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase InhibitorsSriram Tyagarajan, Christine L Andrews, Douglas C Beshore, et al.
Nature Reviews. Clinical Oncology|January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Cancer|May 31, 2013
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinomaLauren E Colbert, Sarah B Fisher, Claire W Hardy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung CancerJeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyRobert F Ozols, Roy S Herbst, Yolonda L Colson, et al.
Oncogene|November 27, 2013
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancerW A Hall, A V Petrova, L E Colbert, et al.
Pageof 97

Showing results (901-910 of 965) with videos related to

Sort By:
Pageof 97
Blood Advances|June 24, 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registrySamuel John, Kevin J Curran, Erin M Hall, et al.
Pediatrics|October 13, 2020
Transitional Care Interventions for Youth With Disabilities: A Systematic ReviewBen B Levy, Jessica Z Song, Dorothy Luong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trialMark R Gilbert, Meihua Wang, Kenneth D Aldape, et al.
ACS Medicinal Chemistry Letters|October 16, 2024
Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase InhibitorsSriram Tyagarajan, Christine L Andrews, Douglas C Beshore, et al.
Nature Reviews. Clinical Oncology|January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Cancer|May 31, 2013
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinomaLauren E Colbert, Sarah B Fisher, Claire W Hardy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung CancerJeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyRobert F Ozols, Roy S Herbst, Yolonda L Colson, et al.
Oncogene|November 27, 2013
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancerW A Hall, A V Petrova, L E Colbert, et al.
Pageof 97